[1] Byrne RA, Stone GW, Ormiston J,et al. Coronary balloon angioplasty, stents, and scaffolds[J].Lancet,2017, 390(10096):781.
[2] Guaricci AI, Pontone G , Fusini L , et al. Additional value of inflammatory biomarkers and carotid artery disease in prediction of significant coronary artery disease as assessed by coronary computed tomography angiography[J].Eur Heart J Cardiovasc Imag,2016, 18(9):2-8.
[3] Magnussen C, Blankenberg S. Biomarkers for heart failure small molecules with high clinical relevance[J].J Int Med,2018,283(6):530-543.
[4] Schmitz J, Owyang A, Oldham E, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper Type 2-associated cytokines[J].Immunity,2005, 23(5):490.
[5] Sowa P, Misiolek M, Zielinski M, et al. Novel interleukin-33 and its soluble ST2 receptor as potential serum biomarkers in parotid gland tumors[J].Exp Biol Med,2018, 243(9):762-769.
[6] Seki K , Sanada S , Kudinova AY , et al. Interleukin-33 prevents apoptosis and improves survival after experimental myocardial infarction through ST2 signaling[J].Circulation,2009, 2(6):684-691.
[7] Abston ED, Barin JG , Cihakova D , et al. IL-33 independently induces eosinophilic pericarditis and cardiac dilation: ST2 improves cardiac function[J].Circulation,2012, 5(3):366-375.
[8] Zhang R , Zhang Y , An T , et al. Prognostic value of sST2 and galectin-3 for death relative to renal function in patients hospitalized for heart failure[J].Biomark Med,2015, 9(5):433-441.
[9] Emdin, M, Aimo, A,Vergaro, G. sST2 predicts outcome in chronic heart failure beyond NT-proBNP and high-sensitivity troponin T[J].J Am Coll Cardiol,2018. 72(19). 2309-2320.
[10] Shimpo M, Morrow DA , Weinberget EO,et al.Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction[J].Circutation,2004, 109(18):2186-2190. |
2019, Vol. 36 
